MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/j.1447-0756.2008.00989.x

Медицинская библиотека · The journal of obstetrics and gynaecology research · 2009

High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.

Jeong Nan Hee, Lee Nak Woo, Kim Hai Joong, Kim Tak, Lee Kyu Wan

СтатьяПеревод пока не подготовлен

Аннотация

AIM: The aim of the present study was to examine the accuracy of high-risk human papillomavirus (HR-HPV) DNA detection as a predictor of residual or recurrent cervical intraepithelial neoplasia (CIN) after treatment of high-grade CIN.

METHODS

Ninety-five women treated by conization and loop electrosurgical excision procedure (LEEP) for high-grade CIN were followed-up with HR-HPV DNA testing (Hybrid Capture II test, Digene Diagnostics, Gaithersburg, MD, USA) and cytology at 3, 6, 12, 18 and 24 months after treatment. The outcome of our study was to detect the presence of CIN using colposcopy-directed biopsy within 24 months after treatment.

RESULTS

Women with recurrent or residual disease did not differ from women who were cured within clinicopathologic parameters at treatment. Pre-treatment HR-HPV testing was positive in all cases. In the recurrent pre-treatment group HR-HPV loads were significantly higher than in the group with no recurrence (1065.5 +/- 852.3 vs 527.7 +/- 669.6, P = 0.003). Residual or recurrent disease was identified in 17 patients (17.9%) during a 24-month period. A Pap smear significantly predicted disease recurrence at the first follow-up visit only. At the 6-month visit, HR-HPV testing showed 100% sensitivity and negative predictive value (NPV). When both a Pap smear and a HR-HPV test were used together, 82% sensitivity, 76% specificity and 95% NPV was noted. Performance of resection margins (odds ratio (OR) 9.8; 95% confidence interval (CI), 3.0-32.7) and post-treatment HR-HPV load >100 RLU (OR 9.3; 95% CI, 2.2-38.2) were also significant.

CONCLUSION

HR-HPV testing in conjunction with Pap smear offers clear advantages over single cytology when monitoring women treated for high-grade CIN.

Для цитирования: Jeong Nan Hee, Lee Nak Woo, Kim Hai Joong, Kim Tak, Lee Kyu Wan. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.. The journal of obstetrics and gynaecology research. 2009. DOI: 10.1111/j.1447-0756.2008.00989.x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.